IDT Biologika - Drug Substance Manufacturing Platforms Service
As one of the world’s leading CDMOs for vaccines, gene and immune therapeutics, and other biologics, IDT Biologika has a wealth of experience in the biological processes and technologies used to produce Viral Vaccines, Viral Vectors, and Oncolytic Viruses.
There are virtually no upstream or downstream methods used today that we do not offer. Every process is different, so when process technology is not yet defined by our client, we will evaluate the parameters and define which of several leading technologies we offer will be optimal based on past experience and knowledge.
IDT Biologika has extensive experience in processes utilizing hyper stack cell factories, which are well established, well-characterized incubation vessels. We offer flexibility in dimensions from a single level up to 40 levels. Our techniques working with cell factories are well characterized and processes are validated through aseptic process simulations (APS). Clients will often bring an existing process using a cell factory, but the process scale may be limited – CF10 for example – so we will scale the process to commercial volume and may transfer it to CF40 to enlarge the batch size.